{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:09:29Z","timestamp":1794892169864,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13052-016-0320-1","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T12:51:58Z","timestamp":1483447918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Metabolic progression to clinical phenotype in classic Fabry disease"],"prefix":"10.1186","volume":"43","author":[{"given":"Marco","family":"Spada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Pagliardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Biamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Giachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"issue":"5 Suppl","key":"320_CR1","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr. 2004;144(5 Suppl):S20\u20136.","journal-title":"J Pediatr"},{"key":"320_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2013.03.013","volume":"163","author":"M Spada","year":"2013","unstructured":"Spada M, Enea A, Morrone A, Fea A, Porta F. Cornea verticillata and Fabry disease. J Pediatr. 2013;163:609.","journal-title":"J Pediatr"},{"key":"320_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase a--replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345:9\u201316.","journal-title":"N Engl J Med"},{"key":"320_CR4","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A. 2008;105:2812\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"320_CR5","first-page":"741","volume":"2010","author":"SM Rombach","year":"1802","unstructured":"Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta. 1802;2010:741\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"320_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","volume":"29","author":"AC Vedder","year":"2006","unstructured":"Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JM, Hollak CE. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis. 2006;29:106\u201311.","journal-title":"J Inherit Metab Dis"},{"key":"320_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79:31\u201340.","journal-title":"Am J Hum Genet"},{"key":"320_CR8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936\u2009+\u2009919G\u2009>\u2009A (IVS4\u2009+\u2009919G\u2009>\u2009A). Hum Mutat. 2009;30:1397\u2013405.","journal-title":"Hum Mutat"},{"key":"320_CR9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2119\/molmed.2012.00002","volume":"18","author":"YH Chien","year":"2012","unstructured":"Chien YH, Lee NC, Chiang SC, Desnick RJ, Hwu WL. Fabry disease: incidence of the common later-onset \u03b1-galactosidase A IVS4\u2009+\u2009919G\u2009\u2192\u2009A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations. Mol Med. 2012;18:780\u20134.","journal-title":"Mol Med"},{"key":"320_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C T\u00f8ndel","year":"2013","unstructured":"T\u00f8ndel C, Bostad L, Larsen KK, Hirth A, Vikse BE, Houge G, et al. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol. 2013;24:137\u201348.","journal-title":"J Am Soc Nephrol"},{"key":"320_CR11","first-page":"257628","volume":"2015","author":"H Trimarchi","year":"2015","unstructured":"Trimarchi H, Canzonieri R, Muryan A, Schiel A, Araoz A, Forrester M, et al. Copious podocyturia without Proteinuria and with normal renal function in a young adult with fabry disease. Case Rep Nephrol. 2015;2015:257628.","journal-title":"Case Rep Nephrol"},{"key":"320_CR12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40620-016-0271-z","volume":"29","author":"H Trimarchi","year":"2016","unstructured":"Trimarchi H, Canzonieri R, Schiel A, Politei J, Stern A, Andrews J, et al. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients. J Nephrol. 2016;29:791\u20137.","journal-title":"J Nephrol"},{"key":"320_CR13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmedgenet-2014-102872","volume":"52","author":"BE Smid","year":"2015","unstructured":"Smid BE, van der Tol L, Biegstraaten M, Linthorst GE, Hollak CE, Poorthuis BJ. Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet. 2015;52:262\u20138.","journal-title":"J Med Genet"},{"key":"320_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3343\/alm.2013.33.4.274","volume":"33","author":"B Johnson","year":"2013","unstructured":"Johnson B, Mascher H, Mascher D, Legnini E, Hung CY, Dajnoki A, et al. Analysis of lyso-globotriaosylsphingosine in dried blood spots. Ann Lab Med. 2013;33:274\u20138.","journal-title":"Ann Lab Med"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-016-0320-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:09:44Z","timestamp":1498374584000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-016-0320-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/s13052-016-0320-1","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]},"article-number":"1"}}